Back to Screener

Healthcare

Coherus Biosciences Inc(CHRS)

Live Price

Offline

$1.50

-1.64% today

1Y Change

+110.82%

Window

Jun 25, 2025 โ†’ Jun 24, 2026

Market Cap
$210.00M
Revenue Growth
-84.2%
EPS Growth
-680.0%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 25, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Coherus Biosciences Inc (CHRS) is a Healthcare stock with a market cap of $210.00M and listed on NASDAQ. The stock last traded around $1.50 and up 110.8% across the available one-year price window (Jun 25, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -84.2%, EPS growth of -680.0%, a dividend yield of 0.0%. What stands out right now is revenue -84.2%, EPS -680.0%, free cash flow -577.7% with operating margin -429.5% and ROIC -153.1%. Valuation is more restrained than many high-expectation growth names at P/E 1.3 and price/sales 5.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CHRS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CHRS vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CHRS

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CHRS Max Drawdown

-45.82%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CHRS and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 11, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 11, 26
โ€”
Est -0.26
โ€”
โ€”
Est 14341.0B
โ€”
May 11
โ€”
Mar 9, 26
โœ“
-0.34
Est -0.36
+4.3%
12748.0B
Est 13912.0B
-8.4%
Mar 9
โ€”
Nov 6, 25
โœ—
-0.33
Est -0.32
-3.1%
11571.0B
Est 14087.4B
-17.9%
Nov 6
โ€”
Aug 7, 25
โœ—
-0.34
Est -0.31
-9.7%
10254.0B
Est 11986.2B
-14.4%
Aug 7
โ€”
May 12, 25
โœ—
-0.35
Est -0.31
-12.9%
7599.0B
Est 60964.3B
-87.5%
May 12
โ€”
Mar 10, 25
โœ—
-0.28
Est -0.10
-180.0%
54144.0B
Est 60000.0B
-9.8%
Mar 10
โ€”
Nov 6, 24
โœ“
-0.01
Est -0.10
+90.0%
70774.0B
Est 43877.1B
+61.3%
Nov 6
โ€”
Aug 8, 24
โœ“
-0.14
Est -0.21
+33.3%
64979.0B
Est 61370.0B
+5.9%
Aug 8
โ€”
May 9, 24
โœ—
-0.32
Est -0.05
-540.0%
77063.0B
Est 80250.0B
-4.0%
May 9
โ€”
Mar 13, 24
โœ—
-0.62
Est -0.21
-195.2%
91524.0B
Est 96400.0B
-5.1%
Mar 13
โ€”
Nov 6, 23
โœ—
-0.27
Est -0.21
-28.6%
74568.0B
Est 88240.0B
-15.5%
Nov 6
โ€”
Aug 2, 23
โœ“
-0.38
Est -0.52
+26.9%
58716.0B
Est 82240.0B
-28.6%
Aug 2
โ€”
May 8, 23
โœ—
-0.75
Est -0.61
-22.9%
32436.0B
Est 47440.0B
-31.6%
May 8
โ€”
Mar 6, 23
โœ“
-0.60
Est -0.64
+6.3%
45352.0B
Est 47691.2B
-4.9%
Mar 6
โ€”
Nov 8, 22
โœ—
-0.96
Est -0.53
-81.1%
45424.0B
Est 56691.8B
-19.9%
Nov 8
โ€”
Aug 4, 22
โœ“
-0.65
Est -0.96
+32.3%
60151.0B
Est 62035.2B
-3.0%
Aug 4
โ€”
May 5, 22
โœ—
-1.24
Est -0.80
-55.0%
60115.0B
Est 69541.8B
-13.6%
May 5
โ€”
Feb 17, 22
โœ“
-0.60
Est -0.61
+1.6%
73371.0B
Est 82611.0B
-11.2%
Feb 17
โ€”
Nov 8, 21
โœ—
-0.49
Est -0.40
-22.5%
82503.0B
Est 61877.2B
+33.3%
Nov 8
โ€”
Aug 5, 21
โœ—
-0.40
Est -0.25
-60.0%
87643.0B
Est 88180.0B
-0.6%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener